National Pharmacare, Reference-Based Pricing, and Drug R&D: A Critique of the National Forum on Health's Recommendations for Pharmaceutical Policy
In February 1997, the Canadian National Forum on Health presented its recommendations for a pharmaceutical policy for Canada. These recommendations include moving towards a universal coverage, publicly funded drug plan; support for reference-based pricing as a method of containing drug plan costs; and requiring that pharmaceutical companies turn over a portion of their research funds to the national research granting agencies. This paper provides a critical assessment of these policy recommendations, with a focus on whether they are likely to achieve long-term reductions in pharmaceutical and health care expenditures in Canada.
Year of publication: |
1999
|
---|---|
Authors: | Lindsey, Robin ; West, Douglas S. |
Published in: |
Canadian Public Policy. - University of Toronto Press. - Vol. 25.1999, 1, p. 1-27
|
Publisher: |
University of Toronto Press |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
A test of the free riding hypothesis using parking coupon data
Lindsey, Robin, (1993)
-
Predatory pricing in differentiated products retail markets
Lindsey, Robin, (2003)
-
An empirical analysis of retailer participation decisions in a downtown parking coupon program
Lindsey, Robin, (1998)
- More ...